CASI Pharmaceuticals (CASI) Short Interest Ratio & Short Volume $2.23 -0.06 (-2.62%) Closing price 08/27/2025 04:00 PM EasternExtended Trading$2.21 -0.02 (-1.08%) As of 08/27/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CASI Pharmaceuticals Short Interest DataCASI Pharmaceuticals (CASI) has a short interest of 28,500 shares, representing 0.93% of the float (the number of shares available for trading by the public). This marks a 3.64% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3.73 million shares to cover all short positions.Current Short Interest28,500 sharesPrevious Short Interest27,500 sharesChange Vs. Previous Month+3.64%Dollar Volume Sold Short$37.05 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares12,300,000 sharesFloat Size3,080,000 sharesShort Percent of Float0.93%Today's Trading Volume40,474 sharesAverage Trading Volume3,728,146 sharesToday's Volume Vs. Average1% Short Selling CASI Pharmaceuticals? Sign up to receive the latest short interest report for CASI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCASI Short Interest Over TimeCASI Days to Cover Over TimeCASI Percentage of Float Shorted Over Time CASI Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202528,500 shares $37.05 thousand +3.6%0.9%0 $1.30 7/15/202527,500 shares $35.75 thousand -9.2%0.7%0.2 $1.30 6/30/202530,300 shares $35.75 thousand +131.3%0.8%0.3 $1.18 6/15/202513,100 shares $24.10 thousand -35.8%0.3%0.1 $1.84 5/31/202520,400 shares $38.96 thousand +20.7%0.5%2.1 $1.91 5/15/202516,900 shares $30.59 thousand +62.5%0.3%1.8 $1.81 4/30/202510,400 shares $20.18 thousand -46.9%0.2%1.1 $1.94 4/15/202519,600 shares $38.04 thousand +2.6%0.4%1.6 $1.94 3/31/202519,100 shares $41.26 thousand -18.0%0.4%1.3 $2.16 3/15/202523,300 shares $51.35 thousand -15.0%0.5%1.1 $2.20 Get the Latest News and Ratings for CASI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CASI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/202527,400 shares $61.65 thousand -24.1%0.6%0.9 $2.25 2/15/202536,100 shares $90.25 thousand -2.7%0.8%1 $2.50 1/31/202537,100 shares $91.64 thousand +17.0%0.8%1 $2.47 1/15/202531,700 shares $80.52 thousand -48.0%0.8%0.7 $2.54 12/31/202461,000 shares $172.63 thousand +43.5%1.6%1.3 $2.83 12/15/202442,500 shares $132.18 thousand -4.9%1.1%1 $3.11 11/30/202444,700 shares $169.86 thousand -0.5%1.2%1.2 $3.80 11/15/202444,900 shares $239.32 thousand -40.6%1.2%1.5 $5.33 10/31/202475,600 shares $452.84 thousand -31.3%1.9%2.8 $5.99 10/15/2024110,000 shares $613.80 thousand -24.9%2.6%4.1 $5.58 9/30/2024146,500 shares $873.14 thousand -9.4%3.4%4.3 $5.96 9/15/2024161,700 shares $1.16 million -2.9%3.8%0.7 $7.17 8/31/2024166,600 shares $1.10 million -3.1%3.9%0.7 $6.59 8/15/2024172,000 shares $1.13 million -15.1%4.0%0.7 $6.56 7/31/2024202,600 shares $1.47 million -6.9%3.2%0.8 $7.25 7/15/2024217,600 shares $1.36 million -58.9%3.4%0.9 $6.25 6/30/2024529,600 shares $2.91 million +771.1%8.2%2.3 $5.50 6/15/202460,800 shares $189.09 thousand -23.7%0.9%1.1 $3.11 5/31/202479,700 shares $307.96 thousand +50.1%1.3%2 $3.86 5/15/202453,100 shares $180.01 thousand +14.7%0.8%0.3 $3.39 4/30/202446,300 shares $106.49 thousand -25.9%0.7%0.2 $2.30 4/15/202462,500 shares $153.13 thousand -24.0%1.0%0.3 $2.45 3/31/202482,200 shares $296.74 thousand -35.4%1.3%0.4 $3.61 3/15/2024127,300 shares $404.81 thousand +204.6%2.2%0.7 $3.18 2/29/202441,800 shares $233.66 thousand -21.3%0.7%0.2 $5.59 2/15/202453,100 shares $323.38 thousand +0.8%0.9%1.1 $6.09 1/31/202452,700 shares $361.52 thousand +10.0%0.9%1 $6.86 1/15/202447,900 shares $291.23 thousand +74.8%0.8%0.9 $6.08 12/31/202327,400 shares $196.18 thousand -18.7%0.5%0.5 $7.16 12/15/202333,700 shares $206.58 thousand -58.4%0.6%0.6 $6.13Chase, Bank of America, Wells Fargo Preparing for BIG Change (Ad)Thanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in America could soon begin to replace every single dollar in your bank account… With a better, more technologically advanced dollar… Potentially making a lot of people rich in the process.Click here to get the details, because this could be a $21 trillion money revolution. 11/30/202381,000 shares $452.79 thousand -46.4%1.4%1.9 $5.59 11/15/2023151,200 shares $657.72 thousand -33.0%2.5%4.9 $4.35 10/31/2023225,700 shares $911.83 thousand +0.6%3.4%9 $4.04 10/15/2023224,400 shares $587.93 thousand -2.6%3.4%12 $2.62 9/30/2023230,400 shares $589.82 thousand -1.5%3.5%15.8 $2.56 9/15/2023233,900 shares $493.53 thousand -1.6%3.5%22.1 $2.11 8/31/2023237,600 shares $548.86 thousand -1.4%3.6%9.1 $2.31 8/15/2023241,000 shares $535.02 thousand +2.4%3.6%8.1 $2.22 7/31/2023235,300 shares $571.78 thousand -3.6%3.5%7.7 $2.43 7/15/2023244,100 shares $646.87 thousand -2.6%3.7%8.2 $2.65 6/30/2023250,700 shares $624.24 thousand -7.4%3.8%6.9 $2.49 6/15/2023270,800 shares $557.85 thousand +12.6%4.1%5.2 $2.06 5/31/2023240,500 shares $678.21 thousand -5.1%3.4%6.5 $2.82 5/15/2023253,300 shares $640.65 thousand -0.7%3.6%7.3 $2.53 4/30/2023255,200 shares $730.38 thousand -5.0%3.6%7.3 $2.86 4/15/2023268,700 shares $964.63 thousand +6.5%3.6%7.1 $3.59 3/31/2023252,200 shares $585.10 thousand +3.4%2.7%6.4 $2.32 3/15/2023244,000 shares $417.24 thousand -6.1%2.6%9.1 $1.71 2/28/2023259,700 shares $501.22 thousand -1.7%2.8%8.3 $1.93 2/15/2023264,300 shares $509.78 thousand +0.9%2.2%8 $1.93 1/31/2023262,000 shares $534.48 thousand -5.7%2.0%7.8 $2.04 1/15/2023277,800 shares $548.66 thousand -5.9%2.1%8.2 $1.98 12/30/2022295,200 shares $528.41 thousand +44.1%2.3%8.7 $1.79 12/15/2022204,900 shares $370.87 thousand +77.6%1.6%5.5 $1.81 11/30/2022115,400 shares $229.65 thousand +27.4%0.9%2.6 $1.99 11/15/202290,600 shares $176.67 thousand -13.6%0.7%1.6 $1.95 10/31/2022104,900 shares $206.65 thousand -9.6%1.0%0.6 $1.97 10/15/2022116,000 shares $257.52 thousand +26.2%1.1%0.6 $2.22 9/30/202291,900 shares $238.94 thousand -41.5%0.9%0.4 $2.60 9/15/2022157,200 shares $664.96 thousand +28.9%1.5%0.7 $4.23 8/31/2022122,000 shares $457.50 thousand -57.1%1.2%0.6 $3.75 8/15/2022284,500 shares $1.14 million +94.5%2.7%1.3 $4.02 7/31/2022146,300 shares $361.36 thousand -18.8%1.4%1.5 $2.47 7/15/2022180,100 shares $491.67 thousand -14.9%1.7%2.5 $2.73 6/30/2022211,700 shares $605.46 thousand +28.9%2.0%3.1 $2.86 6/15/2022164,300 shares $509.33 thousand +89.9%1.8%2.4 $3.10 5/31/202286,500 shares $297.56 thousand -85.9%N/A1.4 $3.44 5/15/2022612,700 shares $213.53 thousand +2.1%0.7%1.8 $0.35 4/30/2022600,200 shares $258.09 thousand -5.2%0.7%1.5 $0.43 4/15/2022633,400 shares $393.34 thousand -26.7%0.7%1.3 $0.62 3/31/2022863,900 shares $699.50 thousand -10.8%1.0%1.4 $0.81 3/15/2022968,800 shares $773.97 thousand -19.3%1.1%1.5 $0.80 2/28/20221,200,000 shares $1.01 million -4.0%1.4%1.6 $0.84 2/15/20221,250,000 shares $1.02 million -22.4%1.4%1.4 $0.82 1/31/20221,610,000 shares $1.08 million +1.9%1.8%1.4 $0.67 1/15/20221,580,000 shares $1.14 million -25.8%N/A1.3 $0.72 12/31/20212,130,000 shares $1.70 million -9.4%2.4%1.7 $0.80 12/15/20212,350,000 shares $1.89 million -27.5%2.7%1.6 $0.80 11/30/20213,240,000 shares $2.90 million +14.5%3.7%1.4 $0.90 11/15/20212,830,000 shares $2.89 million -8.7%3.2%1.2 $1.02Chase, Bank of America, Wells Fargo Preparing for BIG Change (Ad)Thanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in America could soon begin to replace every single dollar in your bank account… With a better, more technologically advanced dollar… Potentially making a lot of people rich in the process.Click here to get the details, because this could be a $21 trillion money revolution. 10/29/20213,100,000 shares $3.35 million +12.3%3.5%1.2 $1.08 10/15/20212,760,000 shares $3.17 million +11.7%3.1%1.1 $1.15 9/30/20212,470,000 shares $2.94 million -10.5%2.8%1.1 $1.19 9/15/20212,760,000 shares $4.08 million -34.1%3.1%1.3 $1.48 8/31/20214,190,000 shares $6.70 million +28.9%4.7%3.1 $1.60 8/13/20213,250,000 shares $4.26 million +5.5%3.7%2.6 $1.31 7/30/20213,080,000 shares $3.57 million -2.2%3.5%3.4 $1.16 7/15/20213,150,000 shares $4.22 million -2.8%3.5%2.3 $1.34 6/30/20213,240,000 shares $5.02 million -40.1%3.6%2.2 $1.55 6/15/20215,410,000 shares $8.93 million +1.5%6.1%2.6 $1.65 5/28/20215,330,000 shares $8.53 million +24.0%6.0%2.7 $1.60 5/14/20214,300,000 shares $6.11 million +24.3%4.8%2.3 $1.42 4/30/20213,460,000 shares $6.26 million +52.4%3.9%1.9 $1.81 4/15/20212,270,000 shares $4.27 million +8.6%2.7%1.6 $1.88 3/31/20212,090,000 shares $4.16 million +22.9%2.7%1.7 $1.99 3/15/20211,700,000 shares $4.22 million -3.4%2.3%3.3 $2.48 2/26/20211,760,000 shares $4.38 million +6.7%2.4%3.7 $2.49 2/12/20211,650,000 shares $4.95 million -9.8%2.3%3.2 $3.00 1/29/20211,830,000 shares $6.28 million +2.2%2.5%3.9 $3.43 1/15/20211,790,000 shares $5.96 million -3.2%2.5%3.3 $3.33 12/31/20201,850,000 shares $5.48 million -2.1%2.6%4 $2.96 12/15/20201,890,000 shares $4.59 million +1.6%2.6%4.4 $2.43 11/30/20201,860,000 shares $4.50 million +1.1%2.6%4.7 $2.42 11/15/20201,840,000 shares $3.64 million +4.0%2.5%4.8 $1.98 10/30/20201,770,000 shares $3.42 million +22.1%2.4%4.4 $1.93 10/15/20201,450,000 shares $2.48 million -6.5%2.0%3.4 $1.71 9/30/20201,550,000 shares $2.37 million +0.7%2.1%3.1 $1.53 9/15/20201,540,000 shares $2.62 million +19.4%2.1%3.1 $1.70 8/31/20201,290,000 shares $2.21 million -9.8%1.8%2.8 $1.71 CASI Short Interest - Frequently Asked Questions What is CASI Pharmaceuticals' current short interest? Short interest is the volume of CASI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 28,500 shares of CASI short. 0.93% of CASI Pharmaceuticals' shares are currently sold short. Learn More on CASI Pharmaceuticals' current short interest. What is a good short interest percentage for CASI Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.93% of CASI Pharmaceuticals' floating shares are currently sold short. Is CASI Pharmaceuticals' short interest increasing or decreasing? CASI Pharmaceuticals saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 28,500 shares, an increase of 3.6% from the previous total of 27,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CASI Pharmaceuticals' float size? CASI Pharmaceuticals currently has issued a total of 12,300,000 shares. Some of CASI Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CASI Pharmaceuticals currently has a public float of 3,080,000 shares. How does CASI Pharmaceuticals' short interest compare to its competitors? 0.93% of CASI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CASI Pharmaceuticals: Protara Therapeutics, Inc. (8.29%), Zentalis Pharmaceuticals, Inc. (6.66%), Connect Biopharma Holdings Limited Sponsored ADR (0.08%), Zura Bio Limited (1.38%), Corbus Pharmaceuticals Holdings, Inc. (11.58%), Cognition Therapeutics, Inc. (10.68%), Cassava Sciences, Inc. (13.40%), Cardiol Therapeutics Inc. (2.24%), Skye Bioscience, Inc. (15.17%), Spero Therapeutics, Inc. (2.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short CASI Pharmaceuticals stock? Short selling CASI is an investing strategy that aims to generate trading profit from CASI Pharmaceuticals as its price is falling. CASI shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CASI Pharmaceuticals? A short squeeze for CASI Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CASI, which in turn drives the price of the stock up even further. How often is CASI Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CASI, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Protara Therapeutics Short Squeeze Zentalis Pharmaceuticals Short Squeeze Connect Biopharma Short Squeeze Zura Bio Short Squeeze Corbus Pharmaceuticals Short Squeeze Cognition Therapeutics Short Squeeze Cassava Sciences Short Squeeze Cardiol Therapeutics Short Squeeze Skye Bioscience Short Squeeze Spero Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CASI) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access